pLenti CMV-SLC7A11-sh926R-FLAG-IRES-Hygro Citations (3)

Originally described in: Paracrine Induction of HIF by Glutamate in Breast Cancer: EglN1 Senses Cysteine.
Briggs KJ, Koivunen P, Cao S, Backus KM, Olenchock BA, Patel H, Zhang Q, Signoretti S, Gerfen GJ, Richardson AL, Witkiewicz AK, Cravatt BF, Clardy J, Kaelin WG Jr Cell. 2016 Jun 30;166(1):126-39. doi: 10.1016/j.cell.2016.05.042. PubMed Journal

---

Articles Citing pLenti CMV-SLC7A11-sh926R-FLAG-IRES-Hygro

Articles
YAP/TAZ and ATF4 drive resistance to Sorafenib in hepatocellular carcinoma by preventing ferroptosis. Gao R, Kalathur RKR, Coto-Llerena M, Ercan C, Buechel D, Shuang S, Piscuoglio S, Dill MT, Camargo FD, Christofori G, Tang F. EMBO Mol Med. 2021 Dec 7;13(12):e14351. doi: 10.15252/emmm.202114351. Epub 2021 Oct 19. PubMed
CIC reduces xCT/SLC7A11 expression and glutamate release in glioma. Park JW, Kilic O, Deo M, Jimenez-Cowell K, Demirdizen E, Kim H, Turcan S. Acta Neuropathol Commun. 2023 Jan 16;11(1):13. doi: 10.1186/s40478-023-01507-y. PubMed
NRF2 activation by cysteine as a survival mechanism for triple-negative breast cancer cells. Bottoni L, Minetti A, Realini G, Pio E, Giustarini D, Rossi R, Rocchio C, Franci L, Salvini L, Catona O, D'Aurizio R, Rasa M, Giurisato E, Neri F, Orlandini M, Chiariello M, Galvagni F. Oncogene. 2024 May;43(22):1701-1713. doi: 10.1038/s41388-024-03025-0. Epub 2024 Apr 10. PubMed

If you have published an article using this material, please email us at to have your article added to this page.